Which ototoxic drug primarily affects the vestibular component?
A 36-year-old woman, recently treated for leukemia, is admitted with malaise, chills, and high fever. Gram stain of blood reveals gram-negative bacilli. The initial diagnosis is bacteremia, and parenteral antibiotics are indicated. The patient's record shows a severe urticarial rash, hypotension, and respiratory difficulty after oral penicillin V 6 months ago. What is the most appropriate drug to administer?
What is the drug of choice for treating Chlamydia trachomatis infection during pregnancy?
Which of the following drugs is not part of the ATRIPLA regimen?
Tetracycline chelates with which of the following?
Which of the following statements is NOT true regarding silver sulfadiazine?
Which of the following antimicrobial agents is considered safe during pregnancy?
Which of the following statements about carboxypenicillins is false?
Which of the following drugs is not used in the management of lepra reactions?
Which of the following fluoroquinolones does not require dose adjustment in a patient with creatinine clearance of < 50 mL/min?
Explanation: **Explanation:** Aminoglycosides are notorious for their **ototoxicity**, which can manifest as either **vestibulotoxicity** (vertigo, ataxia, loss of balance) or **cochleotoxicity** (tinnitus, hearing loss). This toxicity is due to the accumulation of the drug in the endolymph and perilymph, leading to the destruction of sensory hair cells. **1. Why Gentamicin is Correct:** Aminoglycosides are traditionally categorized based on their primary site of damage within the inner ear. **Gentamicin** and **Streptomycin** are predominantly **vestibulotoxic**. They selectively damage the hair cells of the vestibular apparatus (semicircular canals and otolith organs), making them the drugs of choice for chemical labyrinthectomy in Meniere’s disease. **2. Why the Other Options are Incorrect:** * **Amikacin, Kanamycin, and Neomycin:** These are primarily **cochleotoxic**. They cause damage to the Organ of Corti, leading to permanent high-frequency hearing loss. * **Netilmicin:** This is considered the **least ototoxic** aminoglycoside among the commonly used agents, though it can affect both components if used in high doses. **Clinical Pearls for NEET-PG:** * **Mnemonic for Vestibulotoxicity:** "**S**top **G**iddiness" (**S**treptomycin, **G**entamicin). * **Mnemonic for Cochleotoxicity:** "**A**ll **K**ids **N**eed **N**oise" (**A**mikacin, **K**anamycin, **N**eomycin, **N**etilmicin). * **Risk Factors:** Ototoxicity is exacerbated by renal impairment, elderly age, and concurrent use of **Loop Diuretics** (e.g., Furosemide). * **Monitoring:** Aminoglycoside-induced hearing loss is irreversible; therefore, baseline and periodic audiometry are recommended during prolonged therapy.
Explanation: **Explanation:** The patient presents with gram-negative bacteremia and a history of **Type I Hypersensitivity (anaphylaxis)** to penicillin, characterized by urticaria, hypotension, and respiratory distress. **Why Aztreonam is correct:** Aztreonam is a **Monobactam** antibiotic. Its unique monocyclic beta-lactam ring structure makes it **non-cross-reactive** with other beta-lactams (penicillins, cephalosporins, and carbapenems), except for ceftazidime. It is the drug of choice for treating serious aerobic gram-negative infections in patients with a documented severe penicillin allergy. **Why incorrect options are wrong:** * **Ampicillin plus Sulbactam:** This is an aminopenicillin combined with a beta-lactamase inhibitor. It is absolutely contraindicated in patients with a history of penicillin anaphylaxis due to the high risk of cross-reactivity. * **Cefazolin:** As a first-generation cephalosporin, it carries a significant risk of cross-reactivity (approx. 1-10%) in penicillin-allergic patients. In cases of life-threatening anaphylaxis, all cephalosporins should generally be avoided unless specifically indicated. * **Imipenem plus Cilastatin:** Carbapenems share a common bicyclic nucleus with penicillins. There is a documented cross-sensitivity (approx. 1%) between penicillins and carbapenems; thus, they are avoided in patients with a history of immediate hypersensitivity. **NEET-PG High-Yield Pearls:** * **Spectrum:** Aztreonam is active **ONLY** against aerobic Gram-negative bacilli (including *Pseudomonas*). It has no activity against Gram-positives or anaerobes ("Lacks the side chain for Gram-positives"). * **Exception to Cross-reactivity:** Aztreonam shares a common side chain with **Ceftazidime**; therefore, cross-allergenicity can occur between these two specific drugs. * **Mechanism:** It binds specifically to **PBP-3**, leading to the formation of long filamentous bacteria and cell lysis.
Explanation: **Explanation:** The drug of choice for *Chlamydia trachomatis* infection in pregnancy has traditionally been **Azithromycin** (1g single dose). However, according to current guidelines (including CDC and WHO), **Amoxicillin (500 mg TID for 7 days)** is a preferred first-line alternative and is the correct answer among the provided options. **1. Why Amoxicillin is Correct:** Amoxicillin is highly effective against *Chlamydia* in the pregnant population. It is a **Category B** drug, meaning it is safe for both the mother and the fetus. While beta-lactams are generally not used for Chlamydia in non-pregnant adults (due to the organism being intracellular), Amoxicillin shows excellent clinical cure rates in pregnant women and lacks the fetal risks associated with other antibiotics. **2. Why Other Options are Incorrect:** * **Metronidazole:** Primarily used for anaerobic infections and *Trichomonas vaginalis*; it is not effective against *Chlamydia*. * **Cefazolin:** A first-generation cephalosporin used mainly for surgical prophylaxis and Gram-positive skin infections; it has no activity against *Chlamydia*. * **Clindamycin:** Used for Bacterial Vaginosis or Pelvic Inflammatory Disease (in combination), but it is not a primary treatment for uncomplicated Chlamydial cervicitis. **3. High-Yield NEET-PG Pearls:** * **Contraindication:** **Doxycycline** (the DOC for non-pregnant adults) is strictly **contraindicated** in pregnancy (Category D) because it causes fetal teeth discoloration and bone growth inhibition. * **Standard DOC:** If Azithromycin is an option, it is usually the top choice due to single-dose compliance. If absent, Amoxicillin is the next best answer. * **Erythromycin:** Previously used but now avoided due to high gastrointestinal side effects. * **Neonatal Complication:** Untreated maternal Chlamydia can lead to **Neonatal Conjunctivitis** (5–12 days post-birth) and **Infantile Pneumonia**.
Explanation: **Explanation:** **ATRIPLA** is a fixed-dose combination (FDC) tablet used as a highly active antiretroviral therapy (HAART) for the treatment of HIV-1 infection. The correct answer is **Nevirapine** because it is not a component of this specific combination. **1. Why Nevirapine is the correct answer:** Atripla consists of three specific drugs: **Tenofovir Disoproxil Fumarate (TDF)**, **Emtricitabine (FTC)**, and **Efavirenz (EFV)**. Nevirapine is a Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI), similar to Efavirenz, but it is not included in the Atripla formulation. Nevirapine is more commonly associated with the "NVP-based" regimens previously used in preventing mother-to-child transmission. **2. Analysis of Incorrect Options:** * **Tenofovir (A):** A Nucleoside Reverse Transcriptase Inhibitor (NRTI) and a core component of Atripla. It is the preferred backbone in many HIV regimens. * **Emtricitabine (C):** An NRTI that is chemically related to Lamivudine. It is a standard component of Atripla. * **Lamivudine (B):** While not technically in the brand-name Atripla (which uses Emtricitabine), many generic versions of this triple combination use Lamivudine interchangeably with Emtricitabine due to their similar efficacy and resistance profiles. However, in the context of the specific "Atripla" brand, Nevirapine is definitively the "odd one out." **High-Yield Clinical Pearls for NEET-PG:** * **Atripla Composition:** Tenofovir + Emtricitabine + Efavirenz (TDF + FTC + EFV). * **Mechanism:** It combines two NRTIs (Tenofovir, Emtricitabine) with one NNRTI (Efavirenz). * **Side Effects:** Efavirenz is notorious for **CNS side effects** (vivid dreams, insomnia, psychosis) and is generally avoided in the first trimester of pregnancy (though guidelines have evolved). * **Current WHO/NACO Guidelines:** The preferred first-line regimen has shifted from Efavirenz-based (Atripla) to **Dolutegravir (DTG)-based** regimens (TLD: Tenofovir + Lamivudine + Dolutegravir) due to better efficacy and higher genetic barrier to resistance.
Explanation: **Explanation:** The correct answer is **D. All of the above.** Tetracyclines are bacteriostatic antibiotics that possess a unique chemical structure containing multiple hydroxyl and carbonyl groups. This structure allows them to act as **chelating agents**, meaning they readily bind to **multivalent metal cations** such as Calcium ($Ca^{2+}$), Magnesium ($Mg^{2+}$), Aluminum ($Al^{3+}$), Iron ($Fe^{2+/3+}$), and Zinc ($Zn^{2+}$). When tetracyclines form these insoluble chelates, their gastrointestinal absorption is significantly impaired. This is why patients are advised not to take tetracyclines with milk (rich in Calcium), antacids (containing Magnesium or Aluminum), or iron supplements. **Analysis of Options:** * **A, B, and C:** Each of these is correct individually. Calcium (found in dairy), Magnesium, and Aluminum (found in common antacids) all form stable, non-absorbable complexes with tetracyclines in the gut. Since all three interfere with the drug's bioavailability, "All of the above" is the most accurate choice. **High-Yield Clinical Pearls for NEET-PG:** 1. **Teeth and Bones:** Tetracycline’s affinity for **Calcium** leads to its deposition in growing teeth and bones. This causes permanent **yellowish-brown discoloration** of teeth and enamel hypoplasia; hence, it is contraindicated in pregnancy and children under 8 years of age. 2. **Drug Interactions:** Always counsel patients to maintain a gap of at least 2 hours between tetracycline administration and the intake of dairy products or antacids. 3. **Exception:** **Doxycycline and Minocycline** are less affected by food and milk compared to older tetracyclines, though they still chelate with iron and antacids. 4. **Fanconi Syndrome:** Use of **outdated (expired) tetracyclines** can lead to proximal renal tubular acidosis (Fanconi Syndrome) due to degradation products like epitetracycline.
Explanation: **Explanation:** Silver sulfadiazine is a topical sulfonamide widely used in burn management. The correct answer is **Option C** because silver sulfadiazine is primarily a **prophylactic agent** rather than a curative one. It has poor eschar penetration; therefore, it cannot reach deep-seated bacteria in an already established infection. For treating established burn sepsis, agents with better tissue penetration, such as **Mafenide acetate**, are preferred. **Analysis of Options:** * **Option A (1% Concentration):** This is a true statement. It is commercially available as a 1% cream (e.g., Silvadene) applied topically. * **Option B (Preventing infections):** This is the primary clinical indication. It is applied to fresh burn wounds to prevent colonization by pathogenic bacteria. * **Option D (Active against Pseudomonas):** This is true. Silver sulfadiazine has a broad spectrum of activity, covering both Gram-positive and Gram-negative bacteria, including *Pseudomonas aeruginosa* and even some fungi like *Candida*. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** It acts by slowly releasing silver ions, which are toxic to microbes, combined with the antibacterial effect of sulfadiazine. * **Mafenide Acetate:** Unlike silver sulfadiazine, it penetrates eschar well but can cause **metabolic acidosis** (due to carbonic anhydrase inhibition) and pain on application. * **Silver Nitrate:** Another topical agent, but it causes black staining of tissues and can lead to electrolyte imbalances (hypochloremia/hyponatremia). * **Adverse Effect:** Silver sulfadiazine can occasionally cause transient leukopenia.
Explanation: **Explanation:** The safety of antimicrobial agents during pregnancy is determined by their potential for teratogenicity or fetal toxicity. **Correct Answer: B. Ampicillin** Ampicillin belongs to the **Penicillin** group of antibiotics. Penicillins, along with Cephalosporins and Erythromycin (except the estolate salt), are considered the safest antibiotics during pregnancy. They are classified as **FDA Category B**, meaning animal studies show no risk and there are no adequate studies in pregnant women, or animal studies show a risk but human studies do not. They do not interfere with fetal organogenesis or cause late-term toxicity. **Incorrect Options:** * **A. Aminoglycosides (e.g., Gentamicin, Streptomycin):** These are contraindicated as they are **ototoxic and nephrotoxic**. They can cross the placenta and cause permanent eighth cranial nerve damage (congenital deafness) in the fetus. * **C. Chloramphenicol:** Use near term can lead to **"Gray Baby Syndrome"** in the neonate. This occurs because the immature fetal liver lacks the enzyme *glucuronyl transferase* required to metabolize the drug, leading to cardiovascular collapse. * **D. Cotrimoxazole:** This is a combination of Sulfamethoxazole and Trimethoprim. Trimethoprim is a **folate antagonist** (risk of neural tube defects in the 1st trimester), and Sulfonamides can displace bilirubin from albumin, leading to **kernicterus** in the newborn if used in the 3rd trimester. **High-Yield NEET-PG Pearls:** * **Safe in Pregnancy (Mnemonic: "PCE"):** **P**enicillins, **C**ephalosporins, **E**rythromycin. * **Avoid (Mnemonic: "SAFE"):** **S**ulfonamides (Kernicterus), **A**minoglycosides (Ototoxicity), **F**luoroquinolones (Cartilage damage), **E**rythromycin estolate (Hepatotoxicity in mother) / **T**etracyclines (Discolored teeth/bone inhibition). * **Drug of choice for UTI in pregnancy:** Nitrofurantoin or Amoxicillin-Clavulanate.
Explanation: **Explanation:** Carboxypenicillins (e.g., **Ticarcillin** and **Carbenicillin**) are extended-spectrum penicillins primarily used for their activity against Gram-negative bacilli. **1. Why Option A is False (The Correct Answer):** Carboxypenicillins are **not typically nephrotoxic**. While they are excreted renally, they do not cause direct tubular damage like aminoglycosides or amphotericin B. Their primary electrolyte-related side effect is **hypokalemia** and **hypernatremia** (due to the high sodium content in the parenteral formulations), rather than renal failure. **2. Analysis of Other Options:** * **Option B (Sensitive to penicillinase):** This is **true**. Carboxypenicillins are easily degraded by staphylococcal beta-lactamases (penicillinase). Therefore, they are often combined with beta-lactamase inhibitors like Clavulanic acid (e.g., Ticar-Clav). * **Option C (Effective against Pseudomonas):** This is **true**. Their defining clinical feature is activity against *Pseudomonas aeruginosa*, though they are less potent than Ureidopenicillins (Piperacillin). * **Option D (Platelet aggregation affected):** This is **true**. Carboxypenicillins can interfere with platelet aggregation by binding to the platelet surface or ADP receptors, leading to an increased bleeding time (though platelet count remains normal). **High-Yield Clinical Pearls for NEET-PG:** * **Sodium Load:** Carbenicillin contains high amounts of sodium (~4.7 mEq/g), which can precipitate **Congestive Heart Failure (CHF)** or edema in susceptible patients. * **Ureidopenicillins vs. Carboxypenicillins:** Piperacillin (a Ureidopenicillin) is generally preferred over Ticarcillin because it has superior anti-pseudomonal activity and lower sodium content. * **Bleeding Risk:** Always monitor bleeding time in patients on high-dose Carbenicillin/Ticarcillin, especially if they are on anticoagulants.
Explanation: ### Explanation The management of leprosy involves two distinct components: killing the bacilli (*Mycobacterium leprae*) and managing immunological complications known as **Lepra Reactions**. **Why Rifampicin is the correct answer:** Rifampicin is a potent bactericidal drug used in the Multi-Drug Therapy (MDT) for leprosy to kill the organism. However, it has **no anti-inflammatory or immunomodulatory properties**. In fact, during a lepra reaction, MDT (including Rifampicin) is usually continued to ensure the infection remains under control, but Rifampicin itself does not treat the reaction. **Analysis of Incorrect Options:** * **Clofazimine:** This drug is unique because it possesses both **leprostatic** and **anti-inflammatory** properties. It is specifically used in the management of Type 2 Lepra Reaction (ENL), especially in chronic or steroid-dependent cases. * **Thalidomide:** This is the **drug of choice for Type 2 Lepra Reaction (ENL)**. It acts by inhibiting TNF-alpha. Note: It is strictly contraindicated in pregnancy due to its high teratogenic potential (phocomelia). * **Chloroquine:** While primarily an antimalarial, Chloroquine has mild anti-inflammatory properties and is used as an adjuvant in treating mild cases of Type 2 Lepra Reaction. **Clinical Pearls for NEET-PG:** * **Type 1 Reaction (Reversal Reaction):** Delayed hypersensitivity (Type IV). Treatment: Corticosteroids (Drug of Choice). * **Type 2 Reaction (Erythema Nodosum Leprosum - ENL):** Immune complex-mediated (Type III). Treatment: Thalidomide (DOC), Corticosteroids, Clofazimine, or Chloroquine. * **Rule of Thumb:** Never stop MDT during a lepra reaction; add anti-inflammatory drugs to the existing regimen.
Explanation: **Explanation:** The correct answer is **Trovafloxacin**. **1. Why Trovafloxacin is correct:** Most fluoroquinolones are primarily eliminated by the kidneys via glomerular filtration and active tubular secretion. Therefore, their dosage must be adjusted in patients with renal impairment (CrCl < 50 mL/min) to prevent toxicity. However, **Trovafloxacin** and **Moxifloxacin** are exceptions. Trovafloxacin is primarily metabolized by the liver and excreted through the bile/feces. Because its clearance is independent of renal function, no dose adjustment is required in patients with renal failure. **2. Why the other options are incorrect:** * **Ciprofloxacin (Option A):** It is the prototype fluoroquinolone and is predominantly excreted unchanged in the urine. It requires significant dose reduction in renal impairment. * **Lomefloxacin (Option C) & Sparfloxacin (Option D):** These are long-acting fluoroquinolones. Lomefloxacin is excreted almost entirely by the kidneys, and Sparfloxacin, while having some biliary excretion, still relies significantly on renal clearance. Both require dose adjustments when CrCl drops below 50 mL/min. **3. NEET-PG High-Yield Clinical Pearls:** * **Mnemonic for Hepatic Clearance:** Remember **"M-T"** (Moxifloxacin and Trovafloxacin) as the fluoroquinolones that are "Safe for the Kidney" (Hepatic elimination). * **Moxifloxacin** is the most frequently tested drug in this category for NEET-PG. It is also known as a "Respiratory Quinolone." * **Trovafloxacin Warning:** Although it doesn't require renal adjustment, its clinical use is severely restricted due to the risk of **severe hepatotoxicity** (liver failure). * **Pefloxacin** is another fluoroquinolone that is primarily metabolized by the liver.
Beta-Lactam Antibiotics
Practice Questions
Aminoglycosides
Practice Questions
Macrolides and Ketolides
Practice Questions
Tetracyclines
Practice Questions
Quinolones
Practice Questions
Sulfonamides and Trimethoprim
Practice Questions
Antimycobacterial Drugs
Practice Questions
Antifungal Agents
Practice Questions
Antiviral Drugs
Practice Questions
Antiparasitic Agents
Practice Questions
Principles of Antimicrobial Selection
Practice Questions
Antimicrobial Resistance
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free